Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05462145 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

A NA study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, sponsored by Kardium.

Active
Registry status
NA
Development phase
549
Enrollment target
18
Study locations

NCT05462145 is a NA study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation that is active but no longer recruiting, run by Kardium. The registered enrollment target is 549 participants, below the 836-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (34% lower). The trial reports 18 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05462145, a NA study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, is active but no longer recruiting, sponsored by Kardium.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
549 participants
Enrollment target
18
Study locations

Study Summary

This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).

Conditions Studied

Paroxysmal Atrial Fibrillation Persistent Atrial Fibrillation

Interventions

  • DEVICE Globe Pulsed Field System

Study Locations (18)

Other

  • Motol and Homolka University Hospital - Prague
  • Heart and Diabetes Center NRW - Bad Oeynhausen
  • Charité Campus Virchow Clinic - Berlin
  • Westpfalz-Klinikum GmbH Kaiserslautern - Kaiserslautern

Florida

  • St. Vincent's Medical Center - Jacksonville
  • Mercy Hospital - Miami

Pennsylvania

  • Doylestown Hospital - Doylestown
  • Hospital of the University of Pennsylvania - Philadelphia

Alabama

  • Grandview Medical Center - Birmingham

Arkansas

  • St. Bernards Medical Center - Jonesboro

California

  • Sutter Health - California Pacific Medical Center - San Francisco

Maryland

  • Johns Hopkins - Baltimore

Michigan

  • Beaumont Hospital - Royal Oak

Trial Details

FieldValue
Enrollment Target 549 participants
Start Date 2023-03-09
Est. Completion 2026-09
Phase NA

Sponsor

Kardium

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05462145

The ClinicalTrials.gov registry entry for NCT05462145 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 549 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 836-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (34% lower). The listed sponsor is Kardium, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Globe Pulsed Field System is the first listed.

NCT05462145 reports 18 study locations spanning 13 distinct geographic areas - top geographies include Other, Florida, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05462145 about?

NCT05462145 is a clinical study titled "Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation". This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).

What is the current status of trial NCT05462145?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 549 participants. The study started on 2023-03-09. Estimated completion is 2026-09.

What conditions does trial NCT05462145 study?

This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation.

What interventions are being tested in trial NCT05462145?

The interventions under investigation include: Globe Pulsed Field System (DEVICE).

Who is sponsoring clinical trial NCT05462145?

This trial is sponsored by Kardium, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05462145 being conducted?

This trial has 18 study locations across Alabama, Arkansas, California, Florida, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Paroxysmal Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Paroxysmal Atrial Fibrillation

All registered trials for this condition

Persistent Atrial Fibrillation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.